2017-03-23,Cytori Reports Fourth Quarter And Full Year 2016 Business And Financial Results
2017-03-17,Cytori To Webcast Fourth Quarter Financial Results On March 23rd
2017-02-15,Cytori Completes Acquisition Of Azaya Therapeutics Assets, Initiates Nanomedicine Program
2017-02-14,Cytori Provides Latest Corporate Update At The 2nd Annual Disruptive Growth & Healthcare Conference
2017-02-06,Cytori Receives U.S. Small Business Designation - Substantially Reduces 2017 FDA Filing Fees
2017-01-19,GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open
2017-01-19,Cytori To Acquire Proprietary Nanoparticle Development Platform To Enhance Regenerative Medicine Leadership Position
2017-01-10,Cytori To Expand Scleroderma Focus To Broader Hand Therapy Franchise Under The Habeo™ Cell Therapy Brand
2017-01-06,Cytori Therapeutics To Provide Corporate Update At 2017 Biotech Showcase™
2016-12-29,Cytori Announces Common Stock Purchase Agreement With Institutional Investor, Lincoln Park Capital Fund, LLC
2016-12-28,Ronald Martell To Join Cytori Therapeutics' Board Of Directors
2016-12-14,Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone
2016-12-05,Cytori To Present At The 9th Annual LD Micro Main Event Conference On December 6th, 2016
2016-12-05,Sustained Clinical Benefit After 3 Year Follow Up In Scleroderma Trial
2016-11-29,Cytori Announces Two Year Follow-Up Published On EU Scleroderma Trial
2016-11-16,Cytori Strengthens Global Intellectual Property Portfolio With Key Patents
2016-11-14,Cytori Granted FDA Orphan Drug Designation For ECCS-50 In Scleroderma
2016-11-09,Cytori Reports Third Quarter 2016 Business And Financial Results
2016-11-04,Cytori To Present Data In Two Distinct Models Of Impaired Wound Healing
2016-10-26,Cytori To Webcast Third Quarter Financial Results On November 9
2016-10-26,Cytori Presents Scleroderma Clinical Trial Data At The 2016 American College Of Rheumatology Annual Meeting
2016-10-24,Cytori Publication On Cytori Cell Therapy For Combined Radiation And Thermal Injury
2016-09-19,BARDA Increases Contract Option With Cytori To Advance Countermeasure Clinical Trial
2016-09-01,Cytori To Present In Investor Events In September 2016
2016-08-22,Cytori Therapeutics Receives Frost & Sullivan 2016 Technology Innovation Award
2016-08-05,Cytori Therapeutics Announced Inducement Grant For New Employee
2016-08-04,Cytori Reports Second Quarter 2016 Business And Financial Results
2016-07-22,Cytori To Webcast Second Quarter Financial Results On August 4
2016-07-19,Cytori Cell Therapy™ Phase I Trial Reports Maxillofacial Bone Regeneration
2016-06-28,Cytori ATHENA Trial For Chronic Ischemic Cardiovascular Disease
2016-06-27,Cytori Cell Therapy Receives Limited Approval For Osteoarthritis In Japan
2016-06-15,Cytori Closes Rights Offering For Gross Proceeds Of $17.1 Million
2016-06-13,Cytori Announces Expiration Of Rights Offering And Estimated Gross Proceeds Of $17.1 Million
2016-06-10,Cytori Cell Therapy™ Leads To Improved Function And Reduced Scar Tissue In A Urinary Injury Model
2016-06-08,Presentation Of Twelve Month Pilot Trial Data Of Cytori® Cell Therapy™ For ACL Reconstruction
2016-06-07,Cytori Announces Enrollment Completion In U.S. Phase III Scleroderma Trial
2016-06-06,Cytori Extends Rights Offering Subscription Period To Friday, June 10, And Adjusts Unit Pricing
2016-05-31,Cytori Announces Commencement Of Subscription Period For Previously Announced Rights Offering
2016-05-25,Cytori Fully Enrolls Pivotal U.S. Phase III Scleroderma Trial
2016-05-17,Cytori Informs Stockholders Of Key Dates Related To Announced Rights Offering
2016-05-17,European Scleroderma Trial Investigating Cytori Cell Therapy To Be Presented In Japan
2016-05-10,Cytori Reports First Quarter 2016 Business And Financial Results
2016-05-10,Cytori Granted Broad European Orphan Drug Designation
2016-05-06,Cytori ATHENA Trial Results Support Symptomatic Benefit From Cytori Cell Therapy
2016-05-05,Cytori Reports Preliminary Preclinical Data Supporting Use Of Cytori Cell Therapy™ For Both The Prevention And Treatment Of Hypertrophic Scars
2016-04-29,Cytori To Webcast First Quarter Financial Results On May 10
2016-04-27,Cytori Announces Timing For Full Enrollment In U.S. Phase III Scleroderma Trial
2016-04-18,Cytori Strengthens Global Patent Portfolio
2016-04-14,Cytori Therapeutics To Present Preliminary Safety And Efficacy Preclinical Data At The 2016 American Burn Association Meeting
2016-03-24,Cytori Update On Its U.S. Phase III Scleroderma Trial
2016-03-23,Cytori Granted SME Status By European Medicines Agency
2016-03-03,Cytori Reports Fourth Quarter And Full Year 2015 Business And Financial Results
2016-02-22,Data Reports Sustained Benefit At Two Years With Single Administration Cytori Cell Therapy For Scleroderma
2016-02-19,Cytori Management To Discuss Scleroderma Clinical Trial Findings
2016-02-10,Scleroderma Two Year Data To Be Presented At The 4th Systemic Sclerosis World Congress
2016-02-08,Cytori Reports Interim Data On U.S. Phase II Osteoarthritis Trial
2016-02-04,Cytori Provides Latest Corporate Update At Source Capital Conference
2016-02-03,Cytori Cell Therapy Safe And Potentially Effective In EU Phase I Erectile Dysfunction Trial
2016-01-25,Cytori Update On Its U.S. Phase III Scleroderma Trial
2016-01-21,Cytori Partner Kerastem Expands US Phase II Trial For Early Stage Hair Loss
2016-01-19,Enrollment Begun On Phase II Clinical Trial In Crohn's Disease
2016-01-12,Cytori Enters Agreement With Idis To Launch Managed Access Program In EMEA
2016-01-05,Cytori Therapeutics To Provide Corporate Update At 2016 Biotech Showcase™
2015-12-18,Cytori Amends Corporate Warrant Agreements Simplifying Capital Structure And Updates On 2015 Operating Cash Burn Guidance
2015-12-11,Cytori To Address Nasdaq Listing Via Nasdaq Hearing Panel
2015-12-02,Top Line Data Demonstrates Sustained Two-Year Benefit Of Cytori Cell Therapy In Treatment Of Scleroderma
2015-12-01,Cytori And Worthington Enter Celase® GMP Distribution Agreement To Facilitate Translational Research
2015-11-30,Topical Administration Of Cytori Cell Therapy Effective In Thermal Burn Approach
2015-11-05,Cytori Reports Third Quarter 2015 Business And Financial Results
2015-10-22,Phase I Trial Of Cytori Cell Therapy For Inflammatory Bowel Disease Published
2015-10-22,Cytori Third Quarter Financial Results Update
2015-10-19,Enrollment Initiated In Cytori European Scleroderma Trial
2015-09-29,Healthcare Sector Stocks Under Review - Celldex Therapeutics, Alexion Pharmaceuticals, Advaxis, BioDelivery Sciences And Cytori Therapeutics
2015-09-15,Cytori Presentation With Scleroderma Twelve Month Follow Up Data Available For Investor Download
2015-09-10,Scleroderma Therapy Benefit Sustained At One Year Follow Up
2015-09-08,Cytori Appoints VP And General Manager Of Cell Therapy
2015-09-04,Insider Trading Alert - SUNE, NRIM And CYTX Traded By Insiders
2015-09-03,Cytori Therapeutics To Provide Corporate Update And Investor Presentation Live, At VirtualInvestorConferences.com September 10
2015-09-03,Enrollment Begins In Cytori Phase III/Pivotal ADRESU Urinary Incontinence Trial
2015-08-06,Cytori Reports Second Quarter 2015 Business And Financial Results
2015-08-06,Enrollment Begins In Cytori U.S. Phase III/Pivotal Scleroderma Trial
2015-07-30,Japanese Approval Trial For Stress Urinary Incontinence Using Cytori Cell Therapy Announced
2015-07-29,Cytori Appoints VP Of Business Development And General Counsel
2015-07-28,Cytori Licensee Kerastem Receives Conditional Approval From FDA For Alopecia Trial
2015-07-27,Cytori Second Quarter Financial Results Update
2015-06-15,Cytori Completes Enrollment In US Phase IIb Osteoarthritis Trial
2015-06-10,Cytori Therapeutics' Preclinical Data For The Treatment Of Thermal Injury Published In The Journal Burns
2015-06-01,Cytori Restructures Its Debt To A $17.7 Million Term Loan
2015-05-28,5 Stocks Under $10 Triggering Breakout Trades
2015-05-11,Cytori Reports First Quarter 2015 Business And Financial Results
2015-05-05,Short Interest In Cytori Therapeutics Drops 18.2%
2015-05-05,Cytori Prices Registered Direct Offering Providing For Up To $25 Million In Equity Financing
2015-04-30,Cytori First Quarter Financial Results Update
2015-04-23,Cytori Reports Preclinical And Mechanistic Data Supporting Use Of Cytori Cell Therapy In Wounds Combining Thermal Burn And Radiation Exposure
2015-04-21,Insider Trading Alert - CYTX, KIRK And BXMT Traded By Insiders
2015-04-13,Cytori Provides Twelve Month Data Update On Scleradec-I Trial
2015-04-08,Cytori CEO Tries His Best to Spin Stem-Cell Company's Setbacks
2015-04-07,Cytori Granted Orphan Drug Status For Cellular Therapeutic In European Union
2015-04-06,Cytori Therapeutics (CYTX) Stock Spikes Today on Chinese Approval of Regenerative Cell Technology
2015-04-06,Cytori And Lorem Vascular Receive Regulatory Clearance In China
2015-03-25,Cytori Launches Celase® GMP Product
2015-03-23,Cytori Presents Thermal Burn Data At The 2015 American Burn Association Meeting
2015-03-13,Cytori Therapeutics (CYTX) Stock: Weak On High Volume Today
2015-03-12,Cytori Reports Fourth Quarter And Full Year 2014 Business And Financial Results
2015-03-06,Cytori To Provide Corporate Update At The 27th Annual ROTH Conference In Laguna Niguel, California
2015-03-04,Cytori Provides Business Update Along With Top-line Unaudited 2014 Financial Results At The Cowen And Company 35th Annual Health Care Conference In Boston
2015-03-03,Cytori To Provide Corporate Update At Cowen And Company 35th Annual Health Care Conference
2015-02-26,FDA Approves Expansion Of Pivotal Scleroderma STAR Trial To 20 Clinical Sites
2015-02-24,Cytori Receives Positive European Opinion On Orphan Drug Status
2015-02-17,Cytori Begins Enrollment In ACT-OA: US Phase II Trial For Knee Osteoarthritis
2015-02-10,Enrollment Begins European Knee Meniscus Injury Pilot Trial To Evaluate Cytori Cell Therapy
2015-01-20,Cytori And Leading Expert Discuss Importance Of 'STAR' Trial And Treatment For Scleroderma Patients
2015-01-12,FDA Approves Cytori U.S. Pivotal Scleroderma Trial
2014-12-26,Cytori Therapeutics Risk Play
2014-12-19,Cytori And BARDA Amend Contract Option To Accelerate The Advancement Of A Thermal Burn Injury Countermeasure
2014-12-18,Cytori To Host An Informational Session On Its Planned U.S. STAR Pivotal Trial With Principal Investigator, Dr. Dinesh Khanna
2014-12-17,Cytori To Provide Corporate Update At 2015 Biotech Showcase™ In San Francisco
2014-12-05,Cytori Therapeutics' Investor Presentation Now Available For On-Demand Viewing
2014-12-04,Cytori Expects New Japan Laws To Boost Adoption Of Cytori Cell Therapy
2014-11-21,Cytori Announces Promising Results In A Feasibility Trial Of Cytori Cell Therapy In Conjunction With Anterior Cruciate Ligament Repair
2014-11-20,Cytori Therapeutics To Provide Corporate Update And Investor Presentation On December 4 Through A Live, Interactive Webcast
2014-11-18,Safety And Feasibility Of Cytori Cell Therapy In Acute Myocardial Infarction Presented At 2014 American Heart Association Meeting
2014-11-06,Cytori Reports Third Quarter 2014 Business And Financial Results
2014-10-24,Cytori To Webcast Third Quarter Financial Results On November 6
2014-10-22,Cytori Therapeutics Receives FDA Approval To Resume ATHENA Trial Enrollment
2014-10-20,Cytori Therapeutics, Inc. Announces Resignation Of Lloyd H. Dean Effective November 1, 2014
2014-10-10,Cytori Therapeutics, Inc. Announces Closing Of Financing
2014-10-09,Cytori Therapeutics Invited To Participate In Trade Mission To Asia With U.S. Secretary Of Commerce
2014-10-08,Cytori Therapeutics, Inc. To Raise $13.5 Million In Registered Direct Offering
2014-09-22,Cytori Consolidates And Restructures Its Operations, Provides Business Update
2014-09-02,Cytori Consolidates European Operations To Newly Opened Welsh Manufacturing Facility
2014-08-19,BARDA Executes Contract Option With Cytori For Continued Development Of Thermal Burn Injury Counter Measure
2014-08-18,Cytori Appoints A New Vice President Of Finance And Chief Financial Officer
2014-08-12,Cytori Cell Therapy Reduces Hand Disability And Pain In Scleroderma Patients
2014-08-11,Cytori Reports Second Quarter 2014 Business And Financial Results
2014-08-05,Cytori Provides Update On ATHENA Trial Status
2014-08-04,Cytori To Webcast Second Quarter Financial Results On August 11
2014-07-22,Cytori Technology Selected For NHLBI Funded Trial In LVAD Patients
2014-07-07,Cytori Receives Notice Of Intent To Exercise First Contract Option From BARDA
2014-06-12,Cytori Appoints Ruud J.P. Jona And Nominates Gail K. Naughton To Board Of Directors
2014-06-06,Cytori Therapeutics Closes Previously Announced $10 Million Offering
2014-06-03,Cytori To Present At The Jefferies 2014 Global Healthcare Conference On June 4
2014-05-30,Cytori Therapeutics To Raise $10 Million In Registered Direct Offering
2014-05-12,Cytori Reports First Quarter 2014 Business And Financial Results
2014-05-01,Cytori To Webcast First Quarter Financial Results On May 12
2014-04-14,Long-Term Outcomes From Cytori Cell Therapy Trial For Heart Failure Published In American Heart Journal
2014-04-02,Cytori Announces Senior Management Changes
2014-03-24,Independent Sports Medicine Study Using Cytori Cell Therapy To Treat ACL Injury Underway In Spain
2014-03-20,Cytori Therapeutics To Present At Regen Med Investor Day March 26 In New York
2014-03-11,Cytori Reports Fourth Quarter And Full Year 2013 Business And Financial Results
2014-03-06,Cytori Therapeutics To Present At The 26th Annual Roth Conference On March 12
2014-03-04,Cytori To Webcast Fourth Quarter And Year End Financial Results On March 11
2014-02-20,5 Stocks Under $10 Ready to Explode
2014-02-14,4 Stocks Under $10 Triggering Breakouts
2014-01-13,Cytori To Initiate U.S. Clinical Trial Of Adipose-Derived Regenerative Cells In Hamstring Injuries
2014-01-07,Cytori Announces Presentation At Biotech Showcase&#8482; On January 13
2013-12-03,Cytori Therapeutics To Present At The LD Micro Conference On December 5
2013-11-21,Cytori Comments On New Legislation For Regenerative Medicine In Japan
2013-11-20,First Week Of January 2014 Options Trading For Cytori Therapeutics (CYTX)
2013-11-07,Biotech Stock Mailbag: Galectin, Keryx, Navidea, Cytori
2013-11-07,Cytori Reports Nine Month And Third Quarter 2013 Business And Financial Results
2013-11-07,Cytori Receives $12 Million For The First Installment From The Lorem Vascular Partnership Equity Agreement
2013-11-06,What Cytori Therapeutics Isn't Telling Investors About Its Asian Partner
2013-11-04,Cytori Licenses Asia-Pacific Cardiovascular, Renal &amp; Diabetes Markets To Lorem Vascular For Up To $531 Million
2013-11-01,Cytori To Webcast Third Quarter Financial Results On November 7
2013-10-10,Cytori Patents Adipose-Derived Cell Therapy For Cardiovascular Disease In Australia
2013-10-09,Gary A. Lyons To Join Cytori Therapeutics&#8217; Board Of Directors
2013-10-08,Cytori Therapeutics Announces Participation At The 2013 Stem Cell Meeting On The Mesa&#8217;s 3rd Annual Regen Med Partnering Forum On October 14th And 15th
2013-10-07,Cytori Obtains Celution&#174; System Approval In Singapore
2013-10-03,First Week Of November 16th Options Trading For Cytori Therapeutics (CYTX)
2013-09-16,CYTX: Insiders Vs. Shorts
2013-08-08,Cytori Reports First Half And 2nd Quarter 2013 Business And Financial Results
2013-08-07,Cytori&#8217;s Celution&#174; System Approved In Australia For Processing And Delivering Adipose-Derived Regenerative Cells
2013-08-01,Cytori To Webcast Second Quarter Financial Results On August 8
2013-07-31,Cytori Divests Puregraft&#174; Products, Licenses Celution&#174; For Alopecia And Options Broader Aesthetic Market Rights
2013-07-09,Cytori Appoints David M. Rickey As Chairman Of The Board Of Directors
2013-07-03,Cytori To Webcast At The JMP Securities Healthcare Conference On July 10, 2013
2013-07-01,Cytori Enters $27 Million Term Loan With Oxford Finance Corporation And Silicon Valley Bank
2013-04-16,4 Health Care Stocks Under $10 to Watch
2013-03-28,Cytori Patents Method Of Treating Renal Diseases Using Adipose-Derived Regenerative Cells
